H75

Pharmaceutical Full Disclosure Act

Introduced·2/10/25

Requires manufacturers to disclose specific information in advertisements for prescription drugs and biological products in North Carolina.

The Pharmaceutical Full Disclosure Act mandates that manufacturers include certain details in advertisements for prescription drugs and biological products in North Carolina. These details include the date the product received FDA approval, the date it became available for purchase, and specifics about any side effects that must be disclosed under federal law. This act aims to ensure consumers have clear and comprehensive information about the risks associated with these products.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Current
Rules, Calendar, and Operations of the House Committee
Next
Committee decision

Sponsors

DDD
3
9
RRRRRRRRR
Democratic CaucusRepublican Caucus

History

Feb 11, 2025

House

Passed 1st Reading

Feb 11, 2025

House

Ref To Com On Rules, Calendar, and Operations of the House

Feb 10, 2025

House

Filed